STJ Stock Quote - St Jude Medical, Stock News, ResearchWarren Buffett Guru Investors

46.72 (1y: +19%)

Market Cap	13.19 B	P/E(ttm)	18.50
Enterprise Value	15.66 B	P/B	3.20

STJ- NYSE (USA)
St Jude Medical, Inc.

Currently 4/5

Business Predictability Rank: 4-Star
Back Testing Results:
Average gain of all 4-Star stocks: 9.8% per year.
% of Stocks that are in still loss if held for 10yrs: 8%.
Read more:
What is Predictability Rank?
Performances of real portfolio
Top Ranked Predictable Companies

$46.72

1 Severe Warning Sign 5 Medium Warning Signs 1 Good Sign

Bookmark

Jump to: Guru Trade | Guru Ownership | Insider Trade

Key Ratios

New Key Statistics Module, Z-Score and F-Score

Market Cap $M	13,188	Revenue $M	5,446	Net Margin (%)	13.7	Z-Score	3.2
Enterprise Value $M	15,074	EPS $	2.5	Operating Margin %	20.0	F-Score	5
P/E(ttm))	18.5	Cash Flow Per Share $	4.4	Pre-tax Margin (%)	18.3	Higher ROA y-y	Y
Price/Book	3.2	10-y EBITDA Growth Rate %	14.4	Quick Ratio	2.6	Cash flow > Earnings	Y
Price/Sales	2.6	5-y EBITDA Growth Rate %	13.7	Current Ratio	2.3	Lower Leverage y-y	Y
Price/Cash Flow	8.0	y-y EBITDA Growth Rate %	6.3	ROA % (ttm)	8.1	Higher Current Ratio y-y	N
Dividend Yield %	2.0	Insider Buy (3m)	0	ROE % (ttm)	18.4	Less Shares Outstanding y-y	N
Payout Ratio %	40.0	Shares Outstanding M	283	ROI % (ttm)	15.1	Gross Margin Increase y-y	N

Gurus Latest Trades with STJ

Please Subscribe to see portfolio changes after the end of the last quarter. Real Time Picks are included for Premium Members only! Plans start from as little as $299/year.

7-Day FREE TRIAL

Number of guru portfolios checked: 80. The trades of Premium Gurus are not included unless they are in your Personalized List

Total Records: 77 Page:1 2 3 4

Ticker	Guru	Date	Action	Impact	Price Range (Average)*	Current Price	Change from Average	Comment	Current Shares
STJ	John Rogers	2013-03-31	Add	0.23%	$36.14 - $43.12 ($40.68)	$ 46.72	15%	Add 24.17%	1,675,741
STJ	James Barrow	2013-03-31	Add	0.06%	$36.14 - $43.12 ($40.68)	$ 46.72	15%	Add 41.47%	2,735,000
STJ	Joel Greenblatt	2013-03-31	Add	0.04%	$36.14 - $43.12 ($40.68)	$ 46.72	15%	Add 24.08%	90,730
STJ	Ken Fisher	2013-03-31	Add	0.01%	$36.14 - $43.12 ($40.68)	$ 46.72	15%	Add 58.51%	308,620
STJ	John Hussman	2013-03-31	Reduce	-0.99%	$36.14 - $43.12 ($40.68)	$ 46.72	15%	Reduce -99.53%	4,900
STJ	Vanguard Health Care Fund	2013-03-31	Reduce	-0.25%	$36.14 - $43.12 ($40.68)	$ 46.72	15%	Reduce -25.82%	7,500,400
STJ	Ray Dalio	2012-12-31	Add	0.13%	$31.37 - $43.69 ($37.37)	$ 46.72	25%	Add 610.98%	418,456
STJ	James Barrow	2012-12-31	Add	0.11%	$31.37 - $43.69 ($37.37)	$ 46.72	25%	Add 452.59%	1,933,300
STJ	Joel Greenblatt	2012-12-31	Add	0.04%	$31.37 - $43.69 ($37.37)	$ 46.72	25%	Add 40.5%	73,123
STJ	Joel Greenblatt	2012-12-31	Add	0.04%	$31.37 - $43.69 ($37.37)	$ 46.72	25%	Add 40.5%	73,123
STJ	Ken Fisher	2012-12-31	Add	0.02%	$31.37 - $43.69 ($37.37)	$ 46.72	25%	Add 471.4%	194,705
STJ	David Dreman	2012-12-31	Reduce	-0.18%	$31.37 - $43.69 ($37.37)	$ 46.72	25%	Reduce -54.46%	144,614
STJ	Ken Fisher	2012-09-30	Buy		$36.32 - $43.04 ($39.04)	$ 46.72	20%	New holding, 34075 sh.	34,075
STJ	David Dreman	2012-09-30	Reduce	-0.12%	$36.32 - $43.04 ($39.04)	$ 46.72	20%	Reduce -28.91%	317,543
STJ	Ray Dalio	2012-09-30	Reduce	-0.07%	$36.32 - $43.04 ($39.04)	$ 46.72	20%	Reduce -66.06%	58,856
STJ	David Dreman	2012-06-30	Buy	0.42%	$35.19 - $43.75 ($38.73)	$ 46.72	21%	New holding, 446657 sh.	446,657
STJ	John Rogers	2012-06-30	Add	0.15%	$35.19 - $43.75 ($38.73)	$ 46.72	21%	Add 13.4%	1,469,205
STJ	Joel Greenblatt	2012-06-30	Add	0.14%	$35.19 - $43.75 ($38.73)	$ 46.72	21%	Add 255.55%	64,984
STJ	Ray Dalio	2012-06-30	Add	0.09%	$35.19 - $43.75 ($38.73)	$ 46.72	21%	Add 1017.07%	173,436
STJ	Andreas Halvorsen	2012-06-30	Sold Out	-0.47%	$35.19 - $43.75 ($38.73)	$ 46.72	21%	Sold Out	0
Real Time Picks are included for Premium Members only!!

*The price and date might not be the actual time and price at which the transactions were made. In the case of institutional owners, the date is stated as the last day of their fiscal quarter. The prices are estimates if no accurate information available. Foreign holdings may not be included.

Total Records: 77 Page:1 2 3 4

STJ is held by these Gurus:

Ticker	Guru Name	Portfolio Date*	Current Shares	% of Shares Outstanding	% of Total Assets Managed	Change from Last Holdings
STJ	Ken Fisher	2013-03-31	308,620	0.11	0.03	+58.51%
STJ	James Barrow	2013-03-31	2,735,000	0.97	0.2	+41.47%
STJ	John Rogers	2013-03-31	1,675,741	0.59	1.2	+24.17%
STJ	Joel Greenblatt	2013-03-31	90,730	0.03	0.19	+24.08%
STJ	Mario Gabelli	2013-03-31	81,106	0.03	0.02	+16.41%
STJ	David Dreman	2013-03-31	139,110	0.05	0.15	-3.81%
STJ	Ray Dalio	2013-03-31	340,949	0.12	0.13	-18.52%
STJ	Vanguard Health Care Fund	2013-03-31	7,500,400	2.65	1.2	-25.82%
STJ	John Hussman	2013-03-31	4,900	0	0.01	-99.53%

Most recent portfolio changes are included for Premium Members only!

STJ: Insider Buys/Sells

Click Here for All Insider Trades.

Insider	Position	Date	Trades	Shares	Trade Price ($)	Change (%)	Details
DEVENUTI RICHARD R	Director	2013-05-02	Sell	5,600	$40.64	14.89	view
DEVENUTI RICHARD R	Director	2013-05-02	Sell	5,270	$40.64	14.89	view
Craig Angela D	VP - Global Human Resources	2013-04-26	Sell	3,872	$41.25	13.19	view
ESSIG STUART	Director	2013-04-26	Sell	5,600	$41.3	13.05	view
YARNO WENDY L	Director	2013-04-23	Sell	5,600	$41.18	13.38	view
Fain Eric S	President, IESD	2013-02-07	Sell	2,743	$42.31	10.35	view
CALLAGHAN FRANK J	President, CATD	2013-02-07	Sell	20,000	$42.24	10.54	view
Craig Angela D	VP - Global Human Resources	2013-02-06	Sell	12,000	$42.11	10.88	view
ROUSSEAU MICHAEL T	Group President	2013-02-06	Sell	65,000	$42.5	9.86	view
ROCCA MICHAEL A	Director	2013-02-06	Sell	5,600	$41.45	12.64	view

Press Releases about STJ:

St. Jude Medical Announces Increase in Quarterly Dividend 25 Feb 2013
St. Jude Medical Initiates Landmark Study of Renal... 15 Feb 2013
Riassunto: St. Jude Medical dà inizio ad un importante... 15 Feb 2013
Resumen: Los datos del ensayo clínico RESPECT de St. Jude... 11 Feb 2013
Riassunto: Presentati i dati dello studio clinico RESPECT... 08 Feb 2013

Quarterly/Annual Reports about STJ:

10-Q - ST JUDE MEDICAL INC (0000203077)...: (10-Q) 07 Nov 2012
10-Q - ST JUDE MEDICAL INC (0000203077)...: (10-Q) 07 Aug 2012
10-Q - ST JUDE MEDICAL INC (0000203077)...: (10-Q) 03 May 2012
10-K - ST JUDE MEDICAL INC (0000203077)...: (10-K) 29 Feb 2012
10-Q - ST JUDE MEDICAL INC (0000203077)...: (10-Q) 10 Aug 2011

News about STJ:

Articles On GuruFocus.com

Sarah Ketterer Returns 24 Pct in 2012, Her Top Q4 Buys Feb 25 2013

20 Best Yielding Healthcare Growth Stocks and Which to Buy Feb 02 2013

Why Cooperman and Price Are Betting on Boston Scientific’s Turnaround Dec 31 2012

My Best Healthcare Stock Picks For 2013 | Last Year’s Picks Gained 31.55% Dec 04 2012

Weekly CEO Sells Highlight: Entegris, Honeywell International, St Jude Medical and Wesco Internation Nov 05 2012

My 5 Favorite Health Care Growth Picks of the Next 5 Years Nov 02 2012

Six Stocks Will Benefit If Mitt Romeny Wins Oct 08 2012

Medtronic (MDT) Dividend Stock Analysis 2012 Oct 05 2012

Five Healthy Dividend Growth Stocks to Cure What Ails Your Portfolio May 03 2012

Medtronic - A 'Must Own' Stock for 2012 Mar 07 2012

Add Notes, Comments or Ask Questions

Please log in first

Comments

No comment yet

GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names

Home About Jobs Advertise Site Map Term of Use Privacy Policy RSS Email Alerts Affiliate Program FAQ Contact Us
Disclaimers: GuruFocus.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on GuruFocus.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The gurus may buy and sell securities before and after any particular article and report and information herein is published, with respect to the securities discussed in any article and report posted herein. In no event shall GuruFocus.com be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on GuruFocus.com, or relating to the use of, or inability to use, GuruFocus.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. The gurus listed in this website are not affiliated with GuruFocus.com, LLC. Stock quotes provided by InterActive Data. Fundamental company data provided by Morningstar, updated daily.

FocusBar

Home

Premium Membership

Value Screens

Model Portfolios

Guru Stocks

Market Valuation

By Country

Articles

Submit Articles